Skip to main content
Clinical Trials/NCT00526695
NCT00526695
Unknown
Phase 4

Effects of Sevoflurane in Subanesthetic Concentrations on the Forearm Perfusion, Leukocyte/Thrombocyte Activation, and Endothelial Function After Tourniquet-Induced Ischemia/Reperfusion Injury in the Forearm of Volunteers

University of Zurich1 site in 1 country10 target enrollmentJanuary 2005

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Ischemia/Reperfusion Injury
Sponsor
University of Zurich
Enrollment
10
Locations
1
Primary Endpoint
marker expression on blood cells
Last Updated
17 years ago

Overview

Brief Summary

Sevoflurane preconditioning and cardiovascular protection against ischemia/reperfusion injury.

Study hypothesis: The volatile anesthetic sevoflurane at subanesthetic concentrations achieves endothelial protection against ischemia/reperfusion injury and reduces inflammatory markers in the circulation

Detailed Description

Healthy volunteers are included in the study to investigate endothelial function and platelet activation after preconditioning by sevoflurane in subanesthetic concentrations. Forearm perfusion, endothelial function and leukocyte/thrombocyte activation after tourniquet-induced ischemia/reperfusion injury of the forearm are measured using healthy volunteers in a cross-over design.

Registry
clinicaltrials.gov
Start Date
January 2005
End Date
December 2008
Last Updated
17 years ago
Study Type
Interventional
Study Design
Crossover
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

marker expression on blood cells

Time Frame: December 2008

Study Sites (1)

Loading locations...

Similar Trials